Vascular Structure, Vascular Function and Vascular Aging in Adults Diagnosed With Persistent COVID
ICOPER
1 other identifier
observational
300
1 country
1
Brief Summary
The ICOPER study aims to analyze the structure, vascular function, vascular aging and determining factors in 300 adults diagnosed with Persistent Covid in the field of Primary Health Care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 9, 2023
CompletedFirst Submitted
Initial submission to the registry
April 18, 2023
CompletedFirst Posted
Study publicly available on registry
April 19, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedJune 29, 2023
April 1, 2023
7 months
April 18, 2023
June 28, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Pulse Wave Velocity
Measurement by SphygmoCor System (meters/seg)
1 year
Secondary Outcomes (8)
Carotid intima-media thickness (IMT)
1 year
Cardio Ankle Vascular Index (CAVI)
1 year
Physical Activity
1 year
Eating habits
1 year
Smoking
1 year
- +3 more secondary outcomes
Eligibility Criteria
Through consecutive sampling, 300 subjects will be selected who meet the WHO clinical definition of Persistent Covid established by international Delphi consensus. The subjects will be recruited from the existing records in the Primary Care consultations and in the Internal Medicine Persistent Covid consultation in the Salamanca health area.
You may qualify if:
- History of probable or confirmed SARS-CoV-2 infection, usually 3 months after onset, with symptoms that last at least 2 months and cannot be explained by an alternative diagnosis.
- Common symptoms should include fatigue, shortness of breath, and cognitive dysfunction, and an impact on daily functioning.
You may not qualify if:
- Subjects in a terminal situation.
- Inability to travel to health centers.
- Presenting a history of cardiovascular disease (ischemic heart disease or cerebrovascular disease).
- Glomerular filtration rate of less than 30%.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Primary Care Research Unit of Salamanca (APISAL)
Salamanca, 37005, Spain
Related Publications (2)
Vicente-Gabriel S, Lugones-Sanchez C, Tamayo-Morales O, Vicente Prieto A, Gonzalez-Sanchez S, Conde Martin S, Gomez-Sanchez M, Rodriguez-Sanchez E, Garcia-Ortiz L, Gomez-Sanchez L, Gomez-Marcos MA; EVA-Adic Investigators Group. Relationship between addictions and obesity, physical activity and vascular aging in young adults (EVA-Adic study): a research protocol of a cross-sectional study. Front Public Health. 2024 Jan 26;12:1322437. doi: 10.3389/fpubh.2024.1322437. eCollection 2024.
PMID: 38344236DERIVEDGomez-Sanchez L, Tamayo-Morales O, Suarez-Moreno N, Bermejo-Martin JF, Dominguez-Martin A, Martin-Oterino JA, Martin-Gonzalez JI, Gonzalez-Calle D, Garcia-Garcia A, Lugones-Sanchez C, Gonzalez-Sanchez S, Jimenez-Gomez R, Garcia-Ortiz L, Gomez-Marcos MA, Navarro-Matias E; ICOPER investigators group. Relationship between the structure, function and endothelial damage, and vascular ageing and the biopsychological situation in adults diagnosed with persistent COVID (BioICOPER study). A research protocol of a cross-sectional study. Front Physiol. 2023 Sep 12;14:1236430. doi: 10.3389/fphys.2023.1236430. eCollection 2023.
PMID: 37772064DERIVED
Biospecimen
The analytical data closest to the patient's clinical history prior to SARS-CoV-2 infection will be collected, and the analytical data during the acute SARS-CoV-2 infection, including basal glycemia, HbA1c, TSH, profile lipid, complete blood count, liver profile, creatinine and creatinine albumin index, Vit D and PCR. At the time of inclusion, a fasting test will be carried out, including basal glycemia, HbA1c, TSH, lipid profile, complete blood count, liver profile, creatinine and creatinine albumin index, Vit D, ESR, CRP and interleukins.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 18, 2023
First Posted
April 19, 2023
Study Start
March 9, 2023
Primary Completion
September 30, 2023
Study Completion
December 31, 2023
Last Updated
June 29, 2023
Record last verified: 2023-04